Q3 organic sales grew 12%, driven by 7% pricing growth and 5% higher unit volumes; biologics performed especially well, with Artegraft sales up 18% and RestoreFlow revenue up 34%.
Q3 organic sales grew 12%, driven by 7% pricing growth and 5% higher unit volumes; biologics performed especially well, with Artegraft sales up 18% and RestoreFlow revenue up 34%.
National class action law firm offers free, confidential case evaluations to LeMaitre Vascular investors, tenants, partners, and others whose personal information may have been exposed in the reported data breach.
